Advantra-Z otherwise know as bitter orange or synephrine, is probably the most widely used fat loss supplement. In this video I explain how to buy Advantra Z and what to look for and what not to look for. Here is the Advantra Z that I recommend.
Advantra Z is extract of a citrus fruit (C. aurantium) which contains indirect-acting adrenergic amines (B-sympathicomimetics) in which help utilization of energy substrates, stimulate metabolic processes, help increase uptake of amino acids into muscle, increases lipolysis (breakdown of fat) and could have mild hunger-suppressant effects.
Advantra Z® is the only patented thermogenic nutracuetucal for fat loss and body performance in the world.Click To Tweet
How to Use
Proteinfactory.com suggests a daily range between 100 and 120 mgs of synephrine divided over 2-3 servings per 24 hours. Remember watch for underdosed products that do not contain enough of the synephrine. Go with my recommended brand of Advantra-Z.
Research Studies with Advantra-Z
Eight weeks of supplementation with a multi-ingredient weight loss product enhances body composition, reduces hip and waist girth, and increases energy levels in overweight men and women Journal of the International Society of Sports Nutrition 2013, 10:22 doi:10.1186/1550-2783-10-22
Abstract Background Numerous natural products are marketed and sold claiming to decrease body weight and fat, but few undergo finished product-specific research demonstrating their safety and efficacy. Objective To determine the safety and efficacy of a multi-ingredient supplement containing primarily raspberry ketone, caffeine, capsaicin, garlic, ginger and Citrus aurantium (Prograde Metabolism™ [METABO]) as an adjunct to an eight-week weight loss program. Methods Using a randomized, placebo-controlled, double-blind design, 70 obese but otherwise healthy subjects were randomly assigned to METABO or a placebo and underwent 8 weeks of daily supplementation, a calorie restricted diet, and exercise training. Subjects were tested for changes in body composition, serum adipocytokines (adiponectin, resistin, leptin, TNF-α, IL- 6) and markers of health including heart rate and blood pressure. Results Of the 45 subjects who completed the study, significant differences were observed in: body weight (METABO -2.0% vs. placebo -0.5%, P < 0.01), fat mass (METABO -7.8 vs. placebo – 2.8%, P < 0.001), lean mass (METABO +3.4% vs. placebo +0.8%, P < 0.03), waist girth (METABO -2.0% vs. placebo -0.2%, P < 0.0007), hip girth (METABO -1.7% vs. placebo – 0.4%, P < 0.003), and energy levels per anchored visual analogue scale (VAS) (METABO +29.3% vs. placebo +5.1%, P < 0.04). During the first 4 weeks, effects/trends for maintaining elevated serum leptin (P < 0.03) and decreased serum resistin (P < 0.08) in the METABO group vs. placebo were also observed. No changes in systemic hemodynamics, clinical blood chemistries, adverse events, or dietary intake were noted between groups. Conclusions METABO administration is a safe and effective adjunct to an eight-week diet and exercise weight loss program by augmenting improvements in body composition, waist and hip girth. Adherence to the eight-week weight loss program also led to beneficial changes in body fat in placebo. Ongoing studies to confirm these results and clarify the mechanisms (i.e., biochemical and neuroendocrine mediators) by which METABO exerts the observed salutary